In summary, in women with GDM, glycated albumin is a promising prognostic factor for predicting large-for-date babies, myocardial hypertrophy, as well as neonatal hypoglycemia, hypocalcemia, and polycythemia. This evidence concerns the gene ALB and polycythemia.